Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Sweden / NCT05085756
Active, not recruiting Not applicable

Transdiagnostic Internet Intervention to Improve Mental Health Among University Students

NCT05085756 · tracked via the Priya Life Science Sweden tracker
Sponsor
Uppsala University
Phase
Not applicable
Started
2022-03-14
Last updated
2026-05-07

Condition(s) studied

Psychological Disorder

Investigational drug(s) / intervention(s)

Puma

Puma: One psychoeducation module followed by two transdiagnostic modules tailored to primary depression or anxiety symptoms, followed by three participant-choice modules, and ending with two transdiagnostic modules.

Study summary

This study offers transdiagnostic CBT-based treatment for symptoms of depression and anxiety to university students who have previously responded to the WHO-WMH-ICS survey.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * PHQ-9 cutoff for mild depression * GAD-7 cutoff for mild anxiety Exclusion Criteria: * Suicidal ideation or plans * Severe levels of mental ill-health

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Uppsala University Uppsala Sweden

More Uppsala University trials in Sweden

Establishment of Reference Limits for Blood Lactate Levels in Intensive Care Patients With a Particular Focus on Age and Sex Active, not recruiting
Baby Swim As an Intervention for Depressive Symptoms and Lacking Attachment During the Postpartum Period Recruiting
Long-Term Opioid Therapy in Chronic Non-Cancer Pain: Risks and Benefits Enrolling by invitation
Treating Emergency Laparotomy Incisions With Negative Pressure Wound Therapy Recruiting
Patients With Long-stay at ICU: Factors and Evaluation - Feasibility Study Starting soon
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05085756 on ClinicalTrials.gov ↗ ← All trials in Sweden